ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.652,87
-0,39%
S&P 500
5.297,10
-0,21%
Dow Jones
39.869,38
-0,10%
Euro vs US Dollar
1,08435
-0,22%
Bitcoin
66.340,41
1,69%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Aeglea BioTherapeutics Inc (AGLE)

  7. Aeglea BioTherapeutics Inc (AGLE) News

AGLE

Aeglea BioTherapeutics (AGLE)

Aeglea BioTherapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:AGLE
DatumZeitQuelleÜberschriftSymbolFirma
30/04/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AGLEAeglea BioTherapeutics Inc
25/04/202422h55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGLEAeglea BioTherapeutics Inc
25/04/202422h40Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:AGLEAeglea BioTherapeutics Inc
25/04/202422h21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AGLEAeglea BioTherapeutics Inc
02/04/202422h36Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:AGLEAeglea BioTherapeutics Inc
02/04/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AGLEAeglea BioTherapeutics Inc
02/04/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AGLEAeglea BioTherapeutics Inc
01/04/202422h06Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AGLEAeglea BioTherapeutics Inc
20/03/202412h14Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:AGLEAeglea BioTherapeutics Inc
18/03/202421h06Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:AGLEAeglea BioTherapeutics Inc
18/03/202413h31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AGLEAeglea BioTherapeutics Inc
14/03/202421h12Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:AGLEAeglea BioTherapeutics Inc
28/11/202322h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGLEAeglea BioTherapeutics Inc
28/11/202313h33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AGLEAeglea BioTherapeutics Inc
27/11/202322h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGLEAeglea BioTherapeutics Inc
27/11/202322h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGLEAeglea BioTherapeutics Inc
27/11/202322h32Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AGLEAeglea BioTherapeutics Inc
27/11/202322h27Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AGLEAeglea BioTherapeutics Inc
27/11/202322h25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGLEAeglea BioTherapeutics Inc
27/11/202314h30PR Newswire (US)Aeglea BioTherapeutics Announces Name Change to Spyre Therapeutics, Appoints CEO and Additional Directors, and Expands Leadership Team to Develop Next-Generation Therapeutic Combinations for the Treatment of IBDNASDAQ:AGLEAeglea BioTherapeutics Inc
23/11/202302h45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AGLEAeglea BioTherapeutics Inc
22/11/202323h00PR Newswire (US)Aeglea BioTherapeutics Announces Grants of Inducement AwardsNASDAQ:AGLEAeglea BioTherapeutics Inc
21/11/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AGLEAeglea BioTherapeutics Inc
15/11/202323h18Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:AGLEAeglea BioTherapeutics Inc
15/11/202323h14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AGLEAeglea BioTherapeutics Inc
14/11/202321h13Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:AGLEAeglea BioTherapeutics Inc
09/11/202322h10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AGLEAeglea BioTherapeutics Inc
09/11/202322h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AGLEAeglea BioTherapeutics Inc
09/11/202322h05PR Newswire (US)Aeglea BioTherapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:AGLEAeglea BioTherapeutics Inc
03/11/202322h00PR Newswire (US)Aeglea BioTherapeutics Announces Grants of Inducement AwardsNASDAQ:AGLEAeglea BioTherapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:AGLE

Kürzlich von Ihnen besucht

NASDAQ
MVIR
MULTIVIR INC.
LSE
0Q7E
Debitum Invest Adsits So...
USOTC
GXLM
Grayscale Stellar Lumens (QX)
LSE
RB87
Stan.ch.bk. 25
EU
INEGY
ISHARES IEGY iNAV
COIN
WFCBTC
NASDAQ
UFMC
United Financial Mortgage
LSE
DEPB
LSE
IPSA
Ipsa
LSE
DREF
NYSE
WTRU
Essential Utilities
BFNX
NCABTC
COIN
MEDIGBP
LSE
RA53
London Wall 52
ASX
SXE
Southern Cross Electrica...
BOV
BLAK34
BlackRock DRN
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten